UPF3B Accelerates the Growth of Liver Cancer Cells by Enhancing Autophagy via CDK12
Cell Biology International · 2025
DOI: 10.1002/cbin.70060 ↗At a glance
Journal article in Cell Biology International, 2025. Written by Sijie Xie and 3 co-authors. Institution: Shanghai Putuo People's Hospital, School of Life Science and Technology, Tongji University, Shanghai, China. Major MEDLINE topics: Liver Neoplasms, Autophagy, RNA-Binding Proteins, Cyclin-Dependent Kinases. 65 references. Funded by: This study was supported by grants from National Natural Science Foundation of China (NCSF No. 82073130)..
Abstract (original language)
UPF3B encodes a protein that is part of a postsplicing multi‐protein complex involved in both mRNA nuclear export and mRNA surveillance. Herein, we demonstrate that UPF3B accelerates the proliferation ability of liver cancer cells in vitro and in vivo. Moreover, UPF3B affects epigenetic regulation in human liver cancer cells. Moreover, ATAC‐seq results show that chromatin accessibility is changed between rLV group and rLV‐UPF3B group. Therefore, UPF3B alters transcriptome and proteome in liver cancer. In particular, UPF3B affects the heterogeneity of liver cancer and its microenvironment network. Furthermore, UPF3B promotes the modification ability of H3K4me3, H4K16Ac, and RNAPolII on promoter region of CDK12 and then increased the expression of CDK12. Strikingly, UPF3B enhances the interaction between LC3 and DOR, ATG4 and LC3, ATG3 and LC3, ATG3 and ATG12, ATG3 and ATG16L1, ATG3 and ATG7, ATG3 and ATG9A, and the expression of activated LC3, beclin1 dependent on CDK12. Ultimately, UPF3B increases the autophagy via CDK12 and then enhances the expression of ARAF, RRAS, CyclinD1, C‐myc, PCNA, PKM2, CDK4, YB‐1, H‐Ras via CDK12‐autophagy pathway. Importantly, our results indicate that CDK12 determines the oncogenic function of UPF3B. In conclusions , these results provide basis for research on liver cancer prevention and treatment.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Shanghai Putuo People's Hospital, School of Life Science and Technology, Tongji University, Shanghai, China.
ORCID profiles: Dongdong Lu
Funding
- This study was supported by grants from National Natural Science Foundation of China (NCSF No. 82073130).
Cite
APA
Xie, S., Song, S., Liu, X., & Lu, D. (2025). UPF3B Accelerates the Growth of Liver Cancer Cells by Enhancing Autophagy via CDK12. Cell Biology International. https://doi.org/10.1002/cbin.70060
Vancouver
Xie S, Song S, Liu X, Lu D. UPF3B Accelerates the Growth of Liver Cancer Cells by Enhancing Autophagy via CDK12. Cell Biology International. 2025. doi:10.1002/cbin.70060
BibTeX
@article{Xie2025,
author = {Xie, Sijie and Song, Shuting and Liu, Xinlei and Lu, Dongdong},
title = {UPF3B Accelerates the Growth of Liver Cancer Cells by Enhancing Autophagy via CDK12},
journal = {Cell Biology International},
year = {2025},
doi = {10.1002/cbin.70060}
}
EUVIMED